142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

313824
PHAB's Approach to Internal and External Evaluation

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 10:30 AM - 10:50 AM

Jessica Kronstadt, MPP , Public Health Accreditation Board, Alexandria, VA
The Public Health Accreditation Board (PHAB) accredited its first health departments in February 2013. Now there are more than 200 health departments voluntarily going through the process. As a learning organization, PHAB incorporated a multi-faceted evaluation plan into its work from the beginning as a means to improve its own services to health department applicants and site visitor volunteers and also to begin to respond to questions about the impact of accreditation. This session will provide early findings and results from the initial internal and external evaluations, as well as some of the impact stories from accredited health departments.

Learning Areas:

Administration, management, leadership
Conduct evaluation related to programs, research, and other areas of practice
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines

Learning Objectives:
Describe PHAB’s approach to internal and external evaluation of national accreditation Discuss early findings from PHAB’s evaluation initiatives

Keyword(s): Accreditation, Evaluation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Director of Research and Evaluation for the Public Health Accreditation Board. I am responsible for managing the internal and external evaluation components of PHAB's overall multi-year evaluation plan. I have worked on public health accreditation evaluation types of initiatives for the past 4 years.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.